Patents by Inventor Kerry Ressler

Kerry Ressler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060252761
    Abstract: Methods are provided for facilitating psychological extinction of a deleterious, high-anxiety response that is disproportionate to the threat offered by a given stimulus. An afflicted subject is treated with a sub-antimicrobial dose of D-cycloserine in conjunction with extinction training. The methods are relevant for treatment of anxiety disorders, including phobic disorders and PTSD, in addition to other afflictions such as insomnia and erectile dysfunction.
    Type: Application
    Filed: February 6, 2006
    Publication date: November 9, 2006
    Inventors: Michael Davis, Kerry Ressler, Jason McDevitt
  • Publication number: 20060084659
    Abstract: Methods are provided for facilitating psychological extinction of a deleterious, high-anxiety response that is disproportionate to the threat offered by a given stimulus. An afflicted subject is treated with a cannabinoid reuptake inhibitor in conjunction with extinction training. The methods are relevant for treatment of anxiety disorders, including phobic disorders and PTSD, in addition to other afflictions such as chronic pain, insomnia, and erectile dysfunction.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 20, 2006
    Inventors: Michael Davis, Kerry Ressler, Jasmeer Chhatwal, Jason McDevitt
  • Publication number: 20050096396
    Abstract: Methods for treating an individual with a psychiatric order with a pharmacologic agent that enhances learning or conditioning in combination with a session of psychotherapy are provided. These methods of the invention encompass a variety of methods of psychotherapy, including exposure-based psychotherapy, cognitive psychotherapy, and psychodynamically oriented psychotherapy, and psychiatric orders including fear and anxiety disorders, addictive disorders including substance-abuse disorders, and mood disorders. The pharmacologic agents used for the methods of the present invention are ones that generally enhance learning or conditioning, including those that increase the level of norepinephrine in the brain, those that increase the level of acetylcholine in the brain, and those that enhance N-methyl-D-aspartate (NMDA) receptor transmission in the brain.
    Type: Application
    Filed: August 24, 2004
    Publication date: May 5, 2005
    Applicant: Emory University
    Inventors: Michael Davis, Kerry Ressler